Services
Genomic Testing
Companion Diagnostic Test
Laboratory Developed Tests (LDT)
Solid Tumors
Hematologic Malignancies
Hereditary Cancers
Minimal Residual Disease
RUO Kit Solution
Research Services
Platforms
DNA Sequencing
RNA Sequencing
Other Services
Technology
Our Technology
Publications
Partnerships
About Us
What is Precision Oncology?
Our Company
Our Team
Certificates & Accreditation
News
Join Us
Contact Us
Ch|中文
Search
August 22, 2023
Geneseeq Gains CE Marks for NGS-based Test Kits for Solid Tumors and Hematological Cancer
by Geneseeq
May 25, 2023
GENESEEQ TO SHOWCASE NEW FINDINGS AT ASCO 2023
by Geneseeq
May 16, 2023
Geneseeq published new research on the clinical use of circulating-free DNA fragmentomic in monitoring minimal residual disease for patients with non-small-cell lung cancer
by Geneseeq
March 16, 2021
Geneseeq Collaborates with Illumina to Develop and Commercialize Comprehensive Cancer In-vitro Diagnostic NGS kit
by Geneseeq
Privacy Preference Center
Privacy Preferences
